{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T15:24:49Z","timestamp":1771169089553,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Puma Biotechnology"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.clbc.2019.01.005","type":"journal-article","created":{"date-parts":[[2019,1,29]],"date-time":"2019-01-29T22:30:12Z","timestamp":1548801012000},"page":"200-207.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0619-2838","authenticated-orcid":false,"given":"Rin","family":"Ogiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Niikura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2019.01.005_bib1","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1055-9965.EPI-16-0858","article-title":"Global cancer in women: burden and trends","volume":"26","author":"Torre","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"Suppl 24","key":"10.1016\/j.clbc.2019.01.005_bib2","doi-asserted-by":"crossref","first-page":"5100","DOI":"10.1002\/cncr.30988","article-title":"Disparities in breast cancer survival in the United States (2001-2009): findings from the CONCORD-2 study","volume":"123","author":"Miller","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.01.005_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.prp.2016.09.007","article-title":"Clinicopathologic factors associated with de novo metastatic breast cancer","volume":"212","author":"Shen","year":"2016","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.clbc.2019.01.005_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10549-016-3974-x","article-title":"Ten-year survival in women with primary stage IV breast cancer","volume":"160","author":"Eng","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.01.005_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317705082","article-title":"The effect of distant metastases sites on survival in de novo stage-IV breast cancer: a SEER database analysis","volume":"39","author":"Wu","year":"2017","journal-title":"Tumour Biol"},{"key":"10.1016\/j.clbc.2019.01.005_bib6","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.1200\/JCO.2007.14.1168","article-title":"Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer","volume":"26","author":"Dawood","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.005_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.prp.2014.01.008","article-title":"Prognostic factors in patients with metastatic breast cancer at the time of diagnosis","volume":"210","author":"Ren","year":"2014","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.clbc.2019.01.005_bib8","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/00000421-198812000-00004","article-title":"Stage IV breast cancer: clinical course and survival of patients with osseous versus extraosseous metastases at initial diagnosis. The GOCS (Grupo Oncologico Cooperativo del Sur) experience","volume":"11","author":"Leone","year":"1988","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.005_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10549-016-4066-7","article-title":"Prognostic impact of metastatic pattern in stage IV breast cancer at initial diagnosis","volume":"161","author":"Leone","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.01.005_bib10","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/annonc\/mdx308","article-title":"De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017","volume":"28","author":"Curigliano","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clbc.2019.01.005_bib11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s12032-017-0975-5","article-title":"Advances in systemic therapy for metastatic breast cancer: future perspectives","volume":"34","author":"Corona","year":"2017","journal-title":"Med Oncol"},{"issue":"15 Pt 1","key":"10.1016\/j.clbc.2019.01.005_bib12","first-page":"4429","article-title":"Triple-negative breast cancer: clinical features and patterns of recurrence","volume":"13","author":"Dent","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clbc.2019.01.005_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10549-013-2711-y","article-title":"(2013) Prognosis of metastatic breast cancer subtypes: the hormone receptor\/HER2-positive subtype is associated with the most favorable outcome","volume":"141","author":"Lobbezoo","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.01.005_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/(SICI)1097-0142(19960101)77:1<97::AID-CNCR16>3.0.CO;2-3","article-title":"Younger women with breast carcinoma have a poorer prognosis than older women","volume":"77","author":"Chung","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.01.005_bib15","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/bmj.320.7233.474","article-title":"Factors influencing the effect of age on prognosis in breast cancer: population based study","volume":"320","author":"Kroman","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.clbc.2019.01.005_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10549-009-0388-z","article-title":"Relationship between age at diagnosis and outcome of premenopausal breast cancer: age less than 35 years is a reasonable cut-off for defining young age-onset breast cancer","volume":"119","author":"Han","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2019.01.005_bib17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jamcollsurg.2008.12.001","article-title":"Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease","volume":"208","author":"Gnerlich","year":"2009","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.clbc.2019.01.005_bib18","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1200\/JCO.2015.65.8013","article-title":"Subtype-dependent relationship between young age at diagnosis and breast cancer survival","volume":"34","author":"Partridge","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.005_bib19","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1002\/cncr.31308","article-title":"Breast cancer-specific survival by age: Worse outcomes for the oldest patients","volume":"124","author":"Freedman","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2019.01.005_bib20","unstructured":"SEER*Stat Database: Incidence - SEER 18 Regs Research Data\u00a0+ Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (2000-2014)\u00a0<Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2017, based on the November 2016 submission, The Surveillance Research Program of the Division of Cancer Control and Population Science, National Cancer Institute; Calverton, MD."},{"key":"10.1016\/j.clbc.2019.01.005_bib21","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.clbc.2019.01.005_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.breast.2017.07.017","article-title":"ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3)","volume":"35","author":"Paluch-Shimon","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2019.01.005_bib23","doi-asserted-by":"crossref","first-page":"9254","DOI":"10.1038\/s41598-017-10166-8","article-title":"Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2019.01.005_bib24","unstructured":"National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, Breast Cancer. 2018. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed: August 3, 2018."},{"key":"10.1016\/j.clbc.2019.01.005_bib25","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1200\/JCO.2007.14.2471","article-title":"Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression","volume":"26","author":"Anders","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2019.01.005_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.mrrev.2017.08.001","article-title":"Breast cancer genetics in young women: what do we know?","volume":"774","author":"Gomez-Flores-Ramos","year":"2017","journal-title":"Mutat Res"},{"key":"10.1016\/j.clbc.2019.01.005_bib27","article-title":"Molecular features in young vs elderly breast cancer patients and the impacts on survival disparities by age at diagnosis","author":"Wang","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2019.01.005_bib28","first-page":"65","article-title":"Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008","volume":"41","author":"Wilson","year":"2014","journal-title":"J\u00a0Registry Manag"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918306049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820918306049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:18:38Z","timestamp":1761513518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820918306049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1526820918306049"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Subtype on Survival of Young Patients With Stage IV Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2019.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}